Literature DB >> 8051408

IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses.

V E Schijns1, B L Haagmans, E O Rijke, S Huang, M Aguet, M C Horzinek.   

Abstract

The lymphokine IFN-gamma is a pleiotropic immunomodulator and possesses intrinsic antiviral activity. We studied its significance in the development of antiviral immune responses by using IFN-gamma receptor-deficient (IFN-gamma R-/-) mice. After inoculation with live attenuated pseudorabies virus (PRV), the mutant mice showed no infectivity titers in various tissues, and transient viral Ag expression only in the spleen, similar as in wild-type mice. However, the absence of the IFN-gamma R resulted in increased proliferative splenocyte responses. The PRV-immune animals showed a normal IFN-gamma and IL-2 production, without detectable IL-4, and with decreased IL-10 secretion in response to viral Ag or Con A. Immunohistochemically, an increased ratio of IFN-gamma:IL-4-producing spleen cells was found. After immunization with either live attenuated or inactivated PRV, IFN-gamma R-/- mice produced significantly less antiviral Ab, and more succumbed to challenge infection than the intact control animals. The reduction in Ab titers in the mutant mice correlated with lower protection by their sera in transfer experiments. Our data demonstrate that ablation of the IFN-gamma receptor surprisingly does not inhibit the generation of antiviral Th1-type and increase Th2-type cytokine responses. However, it profoundly impairs the generation of protective antiviral Ab.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051408

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Preferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-β.

Authors:  Yuan Zhao; Yan Fei Adams; Michael Croft
Journal:  Viral Immunol       Date:  2011-09-29       Impact factor: 2.257

2.  Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine.

Authors:  R A Wilson; P S Coulson; C Betts; M A Dowling; L E Smythies
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

3.  Interleukin-12 can directly induce T-helper 1 responses in interferon-gamma (IFN-gamma) receptor-deficient mice, but requires IFN-gamma signalling to downregulate T-helper 2 responses.

Authors:  A P Mountford; P S Coulson; A W Cheever; A Sher; R A Wilson; T A Wynn
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

4.  Molecular cloning and expression of cat interferon-gamma.

Authors:  V E Schijns; C M Wierda; T W Vahlenkamp; M C Horzinek; R J de Groot
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

5.  Cytokine production in the immune response to murine gammaherpesvirus 68.

Authors:  S R Sarawar; R D Cardin; J W Brooks; M Mehrpooya; R A Tripp; P C Doherty
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Attenuation and vaccine potential of aroQ mutants of Corynebacterium pseudotuberculosis.

Authors:  C P Simmons; A L Hodgson; R A Strugnell
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells.

Authors:  B M Dutia; C J Clarke; D J Allen; A A Nash
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection.

Authors:  P Grob; V E Schijns; M F van den Broek; S P Cox; M Ackermann; M Suter
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

9.  Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice.

Authors:  Timo Fischer; Oliver Planz; Lothar Stitz; Hanns-Joachim Rziha
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-gamma.

Authors:  R E Smith; A M Donachie; F H McLaren; A M Mowat
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.